The expression of β-catenin in different subtypes of breast cancer and its clinical significance

被引:42
作者
Li, Shuguang
Li, Shanshan
Sun, Ying [1 ]
Li, Li [1 ]
机构
[1] Shandong Univ, Dept Med Oncol, Ctr Canc, Qilu Hosp, Jinan 250012, Peoples R China
关键词
Breast cancer; beta-catenin; Molecular subtype; Prognosis; E-CADHERIN; TUMOR PROGRESSION; WNT; PATHWAY; CELLS; CARCINOMA; PROTEIN; ALPHA; ADHESION; MARKER;
D O I
10.1007/s13277-014-1975-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Wnt/beta-catenin signaling pathway is implicated in mammary oncogenesis. Reports of beta-catenin expression and its association with outcome in breast cancer are controversial. This study was performed to address the distribution of beta-catenin expression in invasive breast cancer and the correlation between beta-catenin expression and survival of breast cancer patients, and to determine whether beta-catenin was specifically activated in any molecular subtypes. Immunohistochemistry was performed on a tissue microarray containing 169 invasive breast cancers to detect expression of beta-catenin. One hundred thirty one of the 169 patients were followed up. Correlation between beta-catenin expression and different molecular subtypes was determined using chi-square analysis. Overall survival (OS) was analyzed by Kaplan-Meier method with log-rank test. The invasive breast cancer displayed the different patterns of beta-catenin expression from normal tissues with significantly increased cytoplasmic and nuclear staining of beta-catenin. Aberrant beta-catenin expression was observed in 109 in the 169 cases (64.50 %), and there was no difference in beta-catenin expression in the four molecular subtypes. Furthermore, aberrant beta-catenin expression was significantly associated with adverse outcome not only in the entire cohort but also in each of the different molecular subtypes. beta-catenin activation is preferentially found and is associated with a poor clinical outcome in invasive breast cancer independent of molecular subtype.
引用
收藏
页码:7693 / 7698
页数:6
相关论文
共 42 条
[1]   beta-catenin is a target for the ubiquitin-proteasome pathway [J].
Aberle, H ;
Bauer, A ;
Stappert, J ;
Kispert, A ;
Kemler, R .
EMBO JOURNAL, 1997, 16 (13) :3797-3804
[2]   HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer [J].
Andre, Fabrice ;
Mazouni, Chafika ;
Liedtke, Cornelia ;
Kau, Shu-Wan ;
Frye, Debby ;
Green, Marjorie ;
Gonzalez-Angulo, Ana M. ;
Symmans, W. Fraser ;
Hortobagyi, Gabriel N. ;
Pusztai, Lajos .
BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (02) :183-190
[3]  
[Anonymous], 2007, TUMOR GRADING MANUAL
[4]  
Bànkfalvi A, 1999, HISTOPATHOLOGY, V34, P25
[5]   Balancing cell adhesion and Wnt signaling, the key role of β-catenin [J].
Brembeck, FH ;
Rosário, M ;
Birchmeier, W .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2006, 16 (01) :51-59
[6]  
Bukholm IK, 1998, J PATHOL, V185, P262, DOI 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO
[7]  
2-Y
[8]   β-catenin and p53 analyses of a breast carcinoma tissue microarray [J].
Chung, GG ;
Zerkowski, MP ;
Ocal, IT ;
Dolled-Filhart, M ;
Kang, JY ;
Psyrri, A ;
Camp, RL ;
Rimm, DL .
CANCER, 2004, 100 (10) :2084-2092
[9]   Wnt/β-catenin signaling in development and disease [J].
Clevers, Hans .
CELL, 2006, 127 (03) :469-480
[10]   Phospho-regulation of β-catenin adhesion and signaling functions [J].
Daugherty, Rebecca Leadem ;
Gottardi, Cara J. .
PHYSIOLOGY, 2007, 22 (05) :303-309